Retraction notice to "Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression" [Life Sci. 260 (2020) 118423]

Affiliations

• ¹ Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Hematology and Blood Banking, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
• ² Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
• ³ Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
• ⁴ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
• ⁵ Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
• ⁶ Department of Chemical and Materials Engineering, The University of Alabama in Huntsville, AL 35899, USA.
• ⁷ Bioclinicum, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
• ⁸ Immunogenetic Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
• ⁹ Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
• ¹⁰ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.